Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 16 (RPL31P16)

Target: RPL31P16
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L31 pseudogene 16 (RPL31P16) is a processed pseudogene derived from RPL31, the gene encoding the 60S ribosomal protein L31, a structural component of the large ribosomal subunit. RPL31P16 does not produce a functional protein and has no known biological, pathological, or pharmacological activity. Pseudogenes such as RPL31P16 are remnants of genomic evolution that result from duplication or retrotransposition of their parent genes; they are generally considered nonfunctional and not therapeutic targets.

Other names: RPL31_3_207RPL31P16

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 16 (RPL31P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 16 (RPL31P16).

Explore the full profile